Dokumentuaren aipamena
APA (7th ed.) Zitazioa
Rinaldi, I., & Reksodiputro, A. H. (2020). Prognosic Factors Related to The Complete Hematologic Response (CHR) in 3 Months in Leukemia Granulositic Patients Administered with Imatinib Mesylate. Department of Internal Medicine, Faculty of Medicine Universitas Indonesia.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
Rinaldi, Ikhwan, eta Ary Harryanto Reksodiputro. Prognosic Factors Related to The Complete Hematologic Response (CHR) in 3 Months in Leukemia Granulositic Patients Administered with Imatinib Mesylate. Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, 2020.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
Rinaldi, Ikhwan, eta Ary Harryanto Reksodiputro. Prognosic Factors Related to The Complete Hematologic Response (CHR) in 3 Months in Leukemia Granulositic Patients Administered with Imatinib Mesylate. Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, 2020.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.